Impact of health care payer type on HIV stage of illness at time of initiation of antiretroviral therapy in the USA
about
Risk of Cancer among Commercially Insured HIV-Infected Adults on Antiretroviral Therapy.Assessing the cost effectiveness of pre-exposure prophylaxis for HIV prevention in the US.Impact of Health Insurance, ADAP, and Income on HIV Viral Suppression Among US Women in the Women's Interagency HIV Study, 2006-2009.Insurance status and mortality among patients with AIDS.Methods to Obtain a Representative Sample of Ryan White-Funded Patients for a Needs Assessment in Los Angeles County: Results from a Replicable Approach.Increased Antiretroviral Therapy Use and Virologic Suppression in the Bronx in the Context of Multiple HIV Prevention Strategies.
P2860
Impact of health care payer type on HIV stage of illness at time of initiation of antiretroviral therapy in the USA
description
article
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в листопаді 2013
@uk
name
Impact of health care payer ty ...... iretroviral therapy in the USA
@en
Impact of health care payer ty ...... iretroviral therapy in the USA
@nl
type
label
Impact of health care payer ty ...... iretroviral therapy in the USA
@en
Impact of health care payer ty ...... iretroviral therapy in the USA
@nl
prefLabel
Impact of health care payer ty ...... iretroviral therapy in the USA
@en
Impact of health care payer ty ...... iretroviral therapy in the USA
@nl
P2093
P2860
P1433
P1476
Impact of health care payer ty ...... iretroviral therapy in the USA
@en
P2093
Charles Wentworth
Daniel Seekins
Gary Schneider
Stephan Lanes
Timothy Juday
Tony Hebden
P2860
P304
P356
10.1080/09540121.2013.774316
P577
2013-11-01T00:00:00Z